Renal cell carcinoma treated by vaccines for active specific immunotherapy: Correlation of survival with skin testing by autologous tumor cells

Measurement of Delayed Skin-Test Responses

1975 • 516 citations

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.

1975 • 434 citations

Induction of cell-mediated immunity to autologous melanoma cells and regression of metastases after treatment with a melanoma cell vaccine preceded by cyclophosphamide.

1986 • 255 citations

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant.

1988 • 239 citations

Prospectively randomized trial of adjuvant active‐specific immunotherapy for human colorectal cancer

1985 • 164 citations

Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer

1985 • 149 citations

Augmentation of the human immune response by cyclophosphamide.

1982 • 136 citations

Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine.

1984 • 96 citations

Specific immunotherapy of advanced renal carcinoma: Evidence for the polyclonality of metastases

1981 • 88 citations

Specific immunotherapy with suppressor function inhibition for metastatic renal cell carcinoma.

1986 • 54 citations

Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.

1975 • 22 citations

Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.

1975 • 17 citations

Antitumor Immunity Induced by Hybrid Murine Tumor Cells: Requirements for Optimal Immunization<xref ref-type="fn" rid="fn2">2</xref><xref ref-type="fn" rid="fn3">3</xref>

1982 • 9 citations

Human hybrid tumor cells: observations on their production and clinical effects.

1987 • 2 citations